Pharma sector set for 8-10 per cent revenue growth this fiscal
The resultant improvement in operating leverage along with easing pricing pressure in the US generics market will improve…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Crisil
Navigating the shift from low-cost to highest value
The Draft National Pharmaceuticals Policy 2023 advocates a shift from “exceptional quality at low cost” to “exceptional quality at…
Counterfeit products 25-30 per cent of the market in India, reveals ASPA and CRISIL report
The report is based on an independent survey conducted with consumers and retailers covering 12 Indian cities to gauge their…
Pharma exports growth heading for a sharp decline: CRISIL Research
As game changes, companies need to redraw long-term strategies and focus on innovation
GST will slice up to 20 per cent off logistics costs: CRISIL
Complete phasing out of central sales tax and dismantling of check-posts key to realising full benefits
Slower revenue growth at 6-quarter low in Q3FY15: CRISIL Research
Pharmaceuticals forecast to report above average topline growth